Fucosylated N-glycans as early biomarkers of COVID-19 severity
Description
CONCLUSION: In this study we explored the global plasma glycosignature, reflecting the inflammatory state of the organs during the infectious disease. Our findings show the promising potential of glycans as biomarkers of COVID-19 severity.
